Answers are grounded in this paper and cite their sources.
Case reports reveal effective treatment strategies with ECT and lorazepam for schizophrenia with catatonia, indicating legal guardianship is crucial for care.
The classification of psychiatric disorders evolves continuously, as evidenced by the DSM-5's elimination of schizophrenia subtypes (American Psychiatric Association 2013). Despite the reclassification, a robust body of literature continues to support the clinical relevance of catatonic features within schizophrenia, particularly in guiding treatment decisions and prognostic outlooks. Caroff et al. (Psychiatry (Edgemont), 5(12): 42–50, 2024) advocate for short-term use of electroconvulsive therapy (ECT) in cases of schizophrenia with catatonia, emphasizing its efficacy in resistant presentations. British guidelines (J Psychopharmacol 37(4): 327–369, 2023) recommend lorazepam trials as first-line intervention, followed by clozapine when resistance persists, outlining a tiered approach to treatment. We present two cases of adult male patients with schizophrenia and pronounced catatonic symptoms. Both exhibited prolonged hospital stays and were followed for six months post-discharge. These cases underscore how legal guardianship enabled treatment initiation, demonstrate the utility of structured rating scales in quantifying catatonic symptoms, and provide real-world insight into the challenges of implementing guideline-driven care in schizophrenia with catatonia. Our findings suggest practical, evidence-informed strategies for integrating lorazepam, antipsychotics, and ECT—highlighting the importance of individualized treatment planning, proactive legal intervention, and early identification of treatment resistance.
No takes yet. Share an insight, caveat, or question.
Yacques et al. (2025) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: